Heel raises versus prefabricated orthoses in the treatment of posterior heel pain associated with calcaneal apophysitis (Sever's Disease): study protocol for a randomised controlled trial by James, Alicia M et al.
STUDY PROTOCOL Open Access
Heel raises versus prefabricated orthoses in the
treatment of posterior heel pain associated with
calcaneal apophysitis (Sever’s Disease): study
protocol for a randomised controlled trial
Alicia M James
1*, Cylie M Williams
1,2, Terry P Haines
3,4
Abstract
Background: Posterior Heel pain can present in children of 8 to 14 years, associated with or clinically diagnosed as
Sever’s disease, or calcaneal apophysitis. Presently, there are no comparative randomised studies evaluating
treatment options for posterior heel pain in children with the clinical diagnosis of calcaneal apophysitis or Sever’s
disease. This study seeks to compare the clinical efficacy of some currently employed treatment options for the
relief of disability and pain associated with posterior heel pain in children.
Method: Design: Factorial 2 × 2 randomised controlled trial with monthly follow-up for 3 months.
Participants: Children with clinically diagnosed posterior heel pain possibly associated with calcaneal apophysitis/
Sever’s disease (n = 124).
Interventions: Treatment factor 1 will be two types of shoe orthoses: a heel raise or prefabricated orthoses. Both of
these interventions are widely available, mutually exclusive treatment approaches that are relatively low in cost.
Treatment factor 2 will be a footwear prescription/replacement intervention involving a shoe with a firm heel
counter, dual density EVA midsole and rear foot control. The alternate condition in this factor is no footwear pre-
scription/replacement, with the participant wearing their current footwear.
Outcomes: Oxford Foot and Ankle Questionnaire and the Faces pain scale.
Discussion: This will be a randomised trial to compare the efficacy of various treatment options for posterior heel
pain in children that may be associated with calcaneal apophysitis also known as Sever’s disease.
Trial Registration: Trial Number: ACTRN12609000696291
Ethics Approval Southern Health: HREC Ref: 09271B
Introduction
Calcaneal apophysitis (also known as Sever’s disease [1])
is an overuse syndrome thought to be caused by repeti-
tive micro trauma due to increased traction of the calca-
neo-achilles apophysis [1-3]. This condition is
characterised by pain experienced near the lower poster-
ior aspect of the calcaneus in close proximity to the
attachment of the Achilles tendon into the secondary
growth plate of the calcaneus. The calcaneal growth cen-
tre or apophysis appears at approximately seven years of
age [4] and fuses in girls of age approximately thirteen
years and boys of fifteen years [2,5,6], hence this condi-
tion is typically seen in pre-adolescent and adolescent
children. Posterior heel pain reportedly associated with
Calcaneal apophysitis has been reported to comprise 2%-
16% of musculoskeletal injuries in children [2,7,8].
Several theories regarding the pathomechanics of pos-
terior heel pain associated with calcaneal apophysitis in
children have been proposed and can be categorised
into the following:
1. Growth and gastrocnemius/soleus tightness: The
presentation of calcaneal apophysitis is thought to
be due to a period of rapid growth. The rapid
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in the Achilles tendon/triceps surae complex
which amplifies traction on the apophysis [2,3,9].
2. Biomechanics: It has previously been suggested
that children with cavus or planus foot types are
more susceptible to calcaneal apophysitis possibly
due to a harder heel strike placing increase strain
on the affected area [10-12].
3. Infection: Previous authors have reported infection
to have directly caused calcaneal apophysitis
[10,13], though other authors have listed infection
as a differential diagnosis [3,10,11,14].
4. Trauma: Repetitive or single traumatic incidents
have been anecdotally reported to be the causes
of posterior heel pain in calcaneal apophysitsis
[15-17]. There is limited evidence to support this
hypothesis.
5. Obesity: In children obesity has been observed as
an influential factor in calcaneal apophysitis
[1,6,18].
Despite the presence of these theories, there has
been limited clinical data presented to support them
to date.
Recommend treatment paths for posterior heel pain
clinically diagnosed to be associated with calcaneal
apophysitis are varied with most publications relying
upon earlier study recommendations [19]. Treatment
recommendations have included: rest or cessation of
sport [3,20,21], use of heel lifts [2,22,23], use of mobili-
sation [1,2,22], orthoses [21,22,24], stretching or
strengthening [20,21,24], padding for shock absorption/
strapping of heel [24-26], ultrasound/pharmaceutical
prescriptions/ice [20,21,27], immobilisation casting or
crutches [23,26,28] or removal of apophysis [29].
A recent literature review concluded that due to no
valid or reliable data being available regarding calcaneal
apophysitis causation and no clinical trial comparing
treatment approaches, no clinical treatment path can be
determined as “best practice” [19], therefore further
research into treatment options is required.
T h i ss t u d ya i m st oc o m p a r et w oc l i n i c a l l ya p p l i e d
treatment options for the management of posterior heel




This is a factorial randomised controlled trial; two fac-
tors (shoe orthosis and footwear) each with two levels
(heel raise/pre-fabricated orthoses and current footwear/
new athletic footwear respectively), with a three month
Figure 1 Consort flow chart for the study.
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this study is presented (Figure 1). There is no control
group due to this clinical trial being conducted within a
health setting. The trial is also being conducted within a
lower socioeconomic catchment and it is well documen-
ted that there is lower participation in sporting activities
[30] and higher rates of obesity [31,32] in these areas. It
was decided that there was a risk of participant’s not re-
starting physical activity should there be a cessation of
sport group.
Participants and Setting
Children aged between eight and fourteen years will be
recruited from the case load of podiatrists at Cardinia
Casey Community Health Service and Peninsula Health
Service. Patients will be eligible to participate if they
provide a subjective report of pain located at the calca-
neal apophysis (i.e., posterior aspect of heel) with pain
on palpation (positive calcaneal squeeze medial and lat-
eral borders), have not in the last 12 months been diag-
nosed fracture or tumour of the foot or leg and have
not been diagnosed with infective, reactive or rheuma-
toid arthritis.
Interventions
Minimum care for all participants
All participants will receive a standardised icing and
stretching program. The participants will be asked to ice
for 10 minutes a day, during the initial stage of
treatment (one month). The icing treatment will con-
tinue only after sporting activities until the participant is
pain free. The stretching program will be initiated after
the acute phase of calcaneal apophysitis. The stretch will
be an isometric weight-bearing gastrocnemius stretch.
Factor 1: Shoe orthoses
The two levels of shoe orthoses to be investigated are:
1. Heel raise (Figure 2)
2. Prefabricated orthoses (Figure 3).
Both of these interventions represent widely available,
mutually exclusive treatment approaches that are rela-
tively low in cost compared to customised foot orthoses.
Heel raises (Figure 2, 6 mm heel raise) are made from
high density ethylene vinyl acetate (EVA). The EVA heel
raise is designed to reduce the activity of the gastrocne-
mius-soleus-achilles tendon complex on the calcaneo-
achilles attachment by elevating the calcaneus [33]. Heel
raises have been found to provide therapeutic relief in
tendoachilles bursitis, tenosynovitis of Achilles tendons,
and postoperative management of ruptured Achilles ten-
dons [33]. The prefabricated orthoses (Figure 3, Protho-
tic: Firm) intervention is a firm prothotic. The prothotic
is a polyurethane device that is thought to limit prona-
tion by inverting the rear foot with medial varus wed-
ging combined with a small notch in the cuboid area
[34]. The authors have anticipated that the use of a
medical varus wedging device is contraindicated with a
Figure 2 Heel raise shoe orthoses.
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a FPI equal or less then that the child will be excluded
from the study and offered alternative treatment
through the health service. The orthoses will be covered
in a 2 mm blown multi-density EVA cover (Multiform)
which is anticipated to provide shock absorption. There
is currently no literature on the effectiveness of any cus-
tom, semi-custom or prefabricated orthotic device in the
treatment of posterior heel pain associated with calca-
neal apophysitis [35].
Factor 2: Footwear
The two levels of footwear to be investigated are:
1. Current footwear worn by participant
2. New athletic footwear provided by study.
The first condition in this factor entails no direction
for modification of current footwear being provided by
the treating podiatrist. Participants will be requested to
continue wearing their most commonly worn footwear.
This may be school shoes, sports shoes or casual shoes
dependent on the patient.
The alternate condition is the new athletic footwear
prescription/replacement intervention. This involves
provision of a shoe with a firm heel counter, dual den-
sity EVA midsole and rear foot control provided by adi-
das Australia. All shoes provided will be the same
model. The footwear replacement intervention will be
provided to the participant at no cost. All participants
within this group will be given standardised shoe wear-
ing in instructions. Schools within the study area allow
the students to wear athletic footwear as the chosen
footwear style therefore compliance with school uni-
form, sport and play is not anticipated to be an influen-
cing factor. Should an issue arise; the treating podiatrist
will give a letter of support for the footwear choice and
liaise with the school if required.
Instrumentation
The primary outcome measure for this study is the
Oxford Foot and Ankle Questionnaire [36]. This scale
measures the disability associated with foot and ankle
problems in children aged from 5-16 years. This assess-
ment is taken from the perspective of both the child
and the parents and contains “physical” (6 items, Cron-
bach’s alpha = 0.92, parent-child intraclass correlation
coefficient (ICC) = 0.72), “school and play” (4 items,
Cronbach’s alpha = 0.89, parent-child ICC = 0.73) and
“emotional” (4 items, Cronbach’sa l p h a=0 . 8 6 ,p a r e n t -
child ICC = 0.72) domain areas [36].
Secondary outcome measurements will be the Faces
pain scale [37,38] and the Lunge Test [38]. The Faces
pain scale is a seven point verbal rating scale that will
be used to measure severity of pain at rest, on palpation,
during activity and after activity (2 hours post) [36,37].
The test-retest reliability data for six-year-old children
yielded a rank correlation coefficient of 0.79, indicating
that the scores obtained using the faces pain scale are
Figure 3 Prefabricated shoe orthoses.
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produced a high rank correlation coefficient of 0.82 [37].
T h eL u n g eT e s t[ 3 9 ]i sac l i n i c a lm e a s u r eo fa n k l e
dorsiflexion. All participants will be given a standardised
stretching program; measurement of the lunge test will
be recorded to determine any change in ankle dorsiflex-
ion. Intra-rater reliability of experienced raters conduct-
ing this test has been shown to be high when using a
digital inclinometer (average ICC = 0.88, average 95%
limits of agreement = -6.6° - 4.8°) and the clear acrylic
plate (average ICC = 0.89, average 95% limits of agree-
ment = -7.2° - 4.3°) to assist with measurement [39].
The intra-rater reliability of an inexperienced rater has
also been demonstrated to be good to high when using
a digital inclinometer (ICC = 0.77, 95% limits of agree-
ment = -9.1° - 8.3°) and a clear acrylic plate apparatus
(ICC = 0.89, 95% limits of agreement = -8.1° - 4.6°) to
assist in measurement. Inter-rater reliability for inexper-
ienced raters has also been found to be high for when
using either the digital inclinometer (ICC = 0.95, 95%
limits of agreement = -5.7° - 5.7°) and the clear acrylic
plate apparatus (ICC = 0.97, 95% limits of agreement =
-4.7° - 4.7°) [39].
Demographic data, including participant age, gender,
height standard deviation and weight standard deviation,
will be collected for all participants at the baseline
assessment along with the Foot Posture Index-6 (FPI-6),
a clinical standardised measure of a participant’ss t a n d -
ing foot posture [40]. This assessment allows for biome-
chanical factors to be examined, which has been
suggested throughout the literature as a possible causa-
tive factor of calcaneal apophysitis.
Compliance measures
Participants will be asked to complete a star chart or
star sticker placement within their school diary to daily
log compliance with allocated shoe insert intervention/
footwear and record days of ice application and
stretching.
Procedure
All patients presenting to the study locations with heel
pain will be screened for study eligibility by their treat-
ing podiatrist. The parents of patients who meet the
study inclusion criteria will be provided with a written
and verbal explanation of the study, and will be asked to
provide consent for their child to participate. Those for
whom consent to participate is provided will have base-
line assessments undertaken prior to randomisation so
the assessor is blinded to participant group allocation at
this time.
Randomisation will then be undertaken using a per-
muted-block randomisation approach stratified by site.
Randomisation blocks of four or eight participants will
be generated and randomly selected and the resultant
allocation order will be entered into opaque, sealed
envelopes for each site. An investigator not involved in
recruitment or assessment of participants (Terry Haines)
will be responsible for preparing the random allocation
sequence and envelopes. The treatment conditions will
be provided as per the random allocation sequence fol-
lowing completion of the initial assessment.
As remote randomisation is not feasible, a set of tam-
per- evident envelopes will be provided to each partici-
pating site. The envelopes will look identical, and each
will have the trial indication and a sequential number
on it. The envelopes will be opaque and well sealed and
the sequence of opening the envelopes will be moni-
tored regularly by a non participating staff member who
will be responsible for storing and issuing the concealed
allocation envelopes. As there is no off site randomisa-
tions there is potential for bias, the authors have
attempt to mitigate this concern by having the randomi-
sation kept in a secure location
Primary and secondary outcome measurements will be
undertaken at initial presentation and at one, two and
three month follow-up appointments, a tolerance of +/-
1 week will be universally applied. These review
appointment dates are routinely employed for this
patient population and do not represent a departure
from standard practice. Pre-appointment reminder text
message will be employed to promote re-attendance at
follow-up appointments. If a participant does not re-
attend a follow-up appointment, the trial podiatrist will
telephone the participant to attempt to reschedule the
appointment. In the case of non-attendance, the Oxford
Foot and Ankle Questionnaire will be posted with a
reply-paid, addressed envelope. In the case of non-
return of the questionnaire, a telephone consultation
will be provided to offer completion of this
questionnaire.
If a participant’sp a i nd o e sn o tr e s o l v ei nt h et h r e e
month treatment trial an individualised podiatric assess-
ment and treatment will be offered.
Adverse Events
Adverse events will be measured and recorded during
the study. The adverse events may include incidents
such as skin reactions (e.g., blisters or rashes) from the
prefabricated orthoses or heel lifts.
Analysis
The intervention factors will be examined over time on
the primary and secondary outcome measures using
Generalised Estimating Equations. This approach is sui-
table for analysis of longitudinal data and has been
shown to produce unbiased effect estimates with appro-
priate precision in the presence of missing data (missing
completely at random, missing at random or missing
James et al. Journal of Foot and Ankle Research 2010, 3:3
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techniques and does not involve list wise deletion of
participant data where missing data is present [41]. The
analysis will be undertaken to examine the main effects
of the two intervention factors, however, if a significant
“shoe orthoses by footwear” interaction term is identi-
fied, simple effects will be focused upon. The analysis
will follow the intention-to-treat principle.
A follow-up per-protocol analysis will be conducted to
account for participants who do not adhere to their allo-
cated treatment protocol. However, such analyses will be
described as being exploratory and will not be the focus
of the resulting manuscript
Sample size
It is considered that a minimum clinically important
change in the Oxford Ankle Foot Questionnaire in any
domain is 7 points and that based on previous work, the
maximum standard deviation in any domain is 6 points
[36]. Given this experiment has 1 pre-intervention mea-
sure and 3 post-intervention measures, a sample size of
n = 27 per factorial trial cell (i.e., total trial n = 108) will
have >90% power to detect a significant difference of 7
points in any simple contrasts undertaken, assuming a
correlation between assessment points within individual
participants is r = 0.7. To account for 15% drop outs
and incomplete assessments, a total of n = 124 will be
recruited.
Ethical Consideration
Ethical approval for this study has been obtained by the
Southern Health Human Research Ethics Committee
HREC Ref: 09271B. Registration of this randomised con-
trol trial has been completed with the Australian New
Zealand Clinical Trial Registry ACTRN12609000696291.
Conclusion
Posterior heel pain associated with a clinical diagnosis of
calcaneal apophysitis is a common disorder amongst
pre-teen children. Despite this, there is presently no ran-
domised controlled trial of clinical treatment options.
This trial will provide evidence of the efficacy for some
commonly used treatment options from a randomised
trial for the first time. The outcomes of this trial are
therefore likely to strongly influence practice guidelines
and clinical care in this area.
This trial will be limited by its inability to blind out-
come assessors (who are the patients’ treating podia-
trists) though the potential impact of this on trial results
is questionable. The primary outcome measure (Oxford
Foot and Ankle Questionnaire) is a patient and parent
self-report measure, as is the Faces pain scale secondary
outcome, hence there may be limited potential for treat-
ing podiatrists to influence these results. This trial will
be limited by its inability to blind the patients receiving
the treatment modalities. This is believed to more likely
to affect the new footwear factor, as this compares an
active to an inactive treatment level.
This trial is also limited in its ability to test all differ-
ent combinations of possible treatment factors as there
are several other possible treatment approaches avail-
able. The present treatment approaches were selected as
they were considered by the investigators to be some of
the most commonly used strategies available that were
also likely to demonstrate clinical efficacy.
A paucity of research evidence supporting the
theorised pathomechanics and efficacy of treatment
options for a condition such as calcaneal apophysitis
creates uncertainty for clinicians attempting to pursue
an evidence-based treatment approach. These trials, and
other similar trials, are needed to help clinicians better
understand this condition and the efficacy of treatment
approaches they provide.
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